Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results

被引：2
|
作者：
Thomas, Daniel [1 ]
Maxwell, William [2 ]
Archer, Caroline [3 ]
Rigg, Anne [4 ]
Hickish, Tamas [5 ]
Dent, Jo [6 ]
Pettit, Laura [7 ]
Dillon, Marianne [8 ]
Goldsmith, Christy [9 ]
Verrill, Mark [10 ]
Barthelmes, Ludger [11 ]
Khawaja, Saira [1 ]
Sharaiha, Yousef [1 ]
Davies, Mark [8 ]
Arikat, Fawaz [12 ]
Khan, Sahail [1 ]
Munir, Asma [1 ]
Huws, Anita [1 ]
Holt, Simon DavidHenry [1 ]
机构：
[1] Prince Philip Hosp NHS, Llanelli, Wales
[2] Withybush Gen Hosp Pembrokeshire, Haverfordwest, Wales
[3] Queen Alexandra Hosp, Portsmouth, Hants, England
[4] Guys & St Thomas Hosp, London, England
[5] Royal Bournemouth Hosp, Bournemouth, Dorset, England
[6] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England
[7] Royal Shrewsbury Hosp, Shrewsbury, Salop, England
[8] Singleton Hosp, Swansea, W Glam, Wales
[9] Kings Coll Hosp London, London, England
[10] Royal Victoria Infirm, Newcastle, England
[11] North Cumbria Univ Hosp NHS Trust, Carlisle, Cumbria, England
[12] Withybush Gen Hosp, Haverfordwest, Wales
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-OT3-17-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT3-17-03
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
    Fried, Georgeta
    Moskovitz, Mor
    SPRINGERPLUS, 2014, 3 : 1 - 8
  • [2] The impact of Oncotype DX testing on adjuvant chemotherapy decision making in 1-3 node positive breast cancer
    Malam, Yogeshkumar
    Rabie, Mohamed
    Geropantas, Konstantinos
    Alexander, Susanna
    Pain, Simon
    Youssef, Mina
    CANCER REPORTS, 2022, 5 (08)
  • [3] A prospective multi-centre study of the impact of Oncotype DX® on adjuvant treatment decisions in patients in the UK with estrogen receptor positive early breast cancer
    Braybrooke, J.
    Kuchel, A.
    Robinson, T.
    Comins, C.
    Shere, M.
    Varughese, M.
    Sparrow, G.
    Saunders, L.
    Sahu, A.
    Cawthorn, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S466 - S467
  • [4] IMPACT OF THE ONCOTYPE DX® ASSAY ON DECISION-MAKING IN ESTROGEN RECEPTOR POSITIVE EARLY BREAST CANCER
    Jaafar, H.
    Taher, A.
    Quasmeh, K.
    Jaloudi, M.
    BREAST, 2013, 22 : S69 - S69
  • [5] Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
    Dinh, Phuong
    Graham, J. Dinny
    Elder, Elisabeth N.
    Kabir, Masrura
    Doan, Tram B.
    French, James
    Meybodi, Farid
    Hui, Rina
    Wilcken, Nicholas R.
    Harnett, Paul R.
    Hsu, Jeremy
    Stuart, Kirsty E.
    Wang, Tim
    Ahern, Verity
    Brennan, Meagan
    Fox, Stephen B.
    Dear, Rachel F.
    Lim, Elgene
    White, Michelle
    Mann, G. Bruce
    Pathmanathan, Nirmala
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (03) : 501 - 511
  • [6] Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
    Phuong Dinh
    J. Dinny Graham
    Elisabeth N. Elder
    Masrura Kabir
    Tram B. Doan
    James French
    Farid Meybodi
    Rina Hui
    Nicholas R. Wilcken
    Paul R. Harnett
    Jeremy Hsu
    Kirsty E. Stuart
    Tim Wang
    Verity Ahern
    Meagan Brennan
    Stephen B. Fox
    Rachel F. Dear
    Elgene Lim
    Michelle White
    G. Bruce Mann
    Nirmala Pathmanathan
    Breast Cancer Research and Treatment, 2022, 191 : 501 - 511
  • [7] Clinical Outcomes of Breast Cancer Patients with Positive 1-3 Axillary Lymph Nodes
    Huang, C.
    Liam, S.
    Hou, M.
    Huang, M.
    Lin, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S236 - S237
  • [8] The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong
    Leung, Roland C. Y.
    Yau, Thomas C. C.
    Chan, Miranda C. M.
    Chan, Sharon W. W.
    Chan, Terence W. C.
    Tsang, Yvonne Y. Y.
    Wong, Ting Ting
    Chao, Calvin
    Yoshizawa, Carl
    Soong, Inda S.
    Kwan, Wing-Hong
    Kwok, Carol C. H.
    Suen, Joyce S. J.
    Ngan, Roger K. C.
    Cheung, Polly S. Y.
    CLINICAL BREAST CANCER, 2016, 16 (05) : 372 - 378
  • [9] Are breast cancer patients with 1-3 positive nodes suitable candidates for partial breast radiotherapy trial enrollment?
    Truong, P. T.
    Jones, S. O.
    Speers, C. H.
    Kader, H. A.
    Wai, E. S.
    Olivotto, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S206 - S207
  • [10] ECONOMIC EVALUATION OF ONCOTYPE DX® TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGEN-RECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND
    Lacey, L.
    Hornberger, J.
    VALUE IN HEALTH, 2010, 13 (07) : A259 - A259
12345